Suppr超能文献

迈向实现 90-90-90 艾滋病毒目标:南非 2017 年全国艾滋病毒调查结果。

Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.

机构信息

Human Sciences Research Council, Pretoria, South Africa.

School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

BMC Public Health. 2020 Sep 9;20(1):1375. doi: 10.1186/s12889-020-09457-z.

Abstract

BACKGROUND

Measuring progress towards the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 treatment targets is key to assessing progress towards turning the HIV epidemic tide. In 2017, the UNAIDS model estimated that 75% of people living with HIV (PLHIV) globally knew their HIV positive status, 79% of those who knew their status were on antiretroviral therapy (ART), and 81% of those who knew their HIV status and were on ART had a suppressed viral load. The fifth South African national HIV sero-behavioural survey collected nationally representative data that enabled the empirical estimation of these 90-90-90 targets for the country stratified by a variety of key factors.

METHODS

To evaluate progress towards achievement of the 90-90-90 targets for South Africa, data obtained from a national, representative, cross-sectional population-based multi-stage stratified cluster random survey conducted in 2017 were analysed. The Fifth South African National HIV Prevalence, Incidence, Behaviour and Communication Survey (SABSSM V), collected behavioural and biomarker data from individuals residing in households from 1000 randomly selected Small Area Layers (SALs), across all nine provinces of the country. Structured questionnaires were used to collect socio-demographic data, knowledge and perceptions about HIV, and related risk behaviours. Blood samples were collected to test for HIV infection, antiretroviral use, and viral suppression (defined as < 1000 copies/ml). Weighted proportions of study participants aged 15 years and older who tested HIV positive were computed for those who reported awareness of their status (1st 90), and among these, those who were currently on ART (2nd 90) and of these, those who were virally suppressed (3rd 90).

RESULTS

Among persons 15 years and older who were HIV positive, 84.8% were aware of their HIV positive status, of whom 70.7% were currently on ART, with 87.4% of these estimated to have suppressed viral load at the time of the survey. These estimates varied by sex, age, and geo-location type. Relatively higher percentages across all three indicators for women compared to men were observed: 88.7% versus 78.2% for those aware of their status, 72.3% versus 67.7% for on ART, and 89.8% versus 82.3% for viral suppression. Knowing one's positive HIV status increased with age: 74.0, 85.8, and 88.1% for age groups 15-24 years old, 25-49 years old and 50-64 years old, although for those 65 years and older, 78.7% knew their HIV positive status. A similar pattern was observed for the 2nd 90, among those who knew their HIV positive status, 51.7% of 15 to 24 year olds, 70.5% of those aged 25-49 years old, 82.9% of those aged 50-64 years old and 82.4% of those aged 65 years or older were currently on ART. Viral suppression for the above mentioned aged groups, among those who were on ART was 85.2, 87.2, 89.5, and 84.6% respectively. The 90-90-90 indicators for urban areas were 87.7, 66.5, and 87.2%, for rural settings was 85.8, 79.8, and 88.4%, while in commercial farming communities it was 56.2, 67.6 and 81.4%.

CONCLUSIONS

South Africa appears to be on track to achieve the first 90 indicator by 2020. However, it is behind on the second 90 indicator with ART coverage that was ~ 20-percentage points below the target among people who knew their HIV status, this indicates deficiencies around linkage to and retention on ART. Overall viral suppression among those on ART is approaching the target at 87.4%, but this must be interpreted in the context of low reported ART coverage as well as with variation by age and sex. Targeted diagnosis, awareness, and treatment programs for men, young people aged 15-24 years old, people who reside in farming communities, and in specific provinces are needed. More nuanced 90-90-90 estimates within provinces, specifically looking at more granular sub-national level (e.g. districts), are needed to identify gaps in specific regions and to inform provincial interventions.

摘要

背景

衡量联合国艾滋病规划署(UNAIDS)90-90-90 治疗目标的进展情况是评估艾滋病毒流行趋势扭转进展的关键。2017 年,UNAIDS 模型估计,全球 75%的艾滋病毒感染者(PLHIV)知晓其艾滋病毒阳性状况,79%的知晓状况者正在接受抗逆转录病毒治疗(ART),81%的知晓状况并正在接受 ART 治疗者的病毒载量得到抑制。第五次南非全国艾滋病毒血清流行率、行为和交流调查收集了具有代表性的全国性数据,使人们能够根据多种关键因素对该国的这些 90-90-90 目标进行实证估计。

方法

为评估南非实现 90-90-90 目标的进展情况,分析了 2017 年进行的一项全国代表性、横断面、基于人群的多阶段分层聚类随机调查的数据。第五次南非全国艾滋病毒流行率、发病率、行为和传播调查(SABSSM V)从全国 1000 个随机选择的小面积层(SAL)中居住在家庭中的个人收集了行为和生物标志物数据。使用结构化问卷收集社会人口统计学数据、对艾滋病毒的认识和相关风险行为。采集血样检测艾滋病毒感染、抗逆转录病毒的使用情况和病毒抑制情况(定义为 <1000 拷贝/ml)。计算了年龄在 15 岁及以上的艾滋病毒阳性者中,报告知晓其状况者(第 1 个 90)、其中正在接受 ART 治疗者(第 2 个 90)和其中病毒载量得到抑制者(第 3 个 90)的比例。

结果

在年龄在 15 岁及以上的艾滋病毒阳性者中,84.8%知晓其艾滋病毒阳性状况,其中 70.7%正在接受 ART 治疗,估计其中 87.4%的人在调查时病毒载量得到抑制。这些估计因性别、年龄和地理位置类型而异。与男性相比,所有三个指标中女性的比例都相对较高:知晓状况者为 88.7%,而男性为 78.2%;正在接受 ART 治疗者为 72.3%,而男性为 67.7%;病毒载量得到抑制者为 89.8%,而男性为 82.3%。随着年龄的增长,知晓其 HIV 阳性状况的比例增加:15-24 岁年龄组为 74.0%,25-49 岁年龄组为 85.8%,50-64 岁年龄组为 88.1%,而 65 岁及以上年龄组为 78.7%。在第 2 个 90 中也观察到了类似的模式,在那些知晓其 HIV 阳性状况的人中,15-24 岁年龄组的 51.7%、25-49 岁年龄组的 70.5%、50-64 岁年龄组的 82.9%和 65 岁及以上年龄组的 82.4%正在接受 ART 治疗。在正在接受 ART 治疗的上述年龄组中,病毒载量抑制率分别为 85.2%、87.2%、89.5%和 84.6%。城市地区的 90-90-90 指标为 87.7%、66.5%和 87.2%,农村地区为 85.8%、79.8%和 88.4%,商业农业社区为 56.2%、67.6%和 81.4%。

结论

南非似乎有望在 2020 年实现第 1 个 90 目标。然而,在第 2 个 90 目标方面,ART 覆盖率落后于目标,在知晓其 HIV 状况的人群中,ART 覆盖率约为目标值的 20%以下,这表明在将患者转介和维持在 ART 治疗方面存在不足。在正在接受 ART 治疗的人群中,总体病毒载量抑制率接近目标(87.4%),但这必须结合低报告的 ART 覆盖率以及年龄和性别的差异来解释。需要针对男性、15-24 岁的年轻人、居住在农业社区的人以及特定省份开展有针对性的诊断、意识和治疗项目。需要在省内进行更细致的 90-90-90 估计,特别是在更细粒度的省级以下层面(例如,地区),以确定特定地区的差距,并为省级干预措施提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/7487872/2f287e577c65/12889_2020_9457_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验